Go to
current issue
-
Global, regional, and national burden of Burkitt lymphoma from 1990 to 2021 and predictions to 2030: a systematic analysis for the Global Burden of Disease Study 2021 Blood Cancer J. (IF 12.9) Pub Date : 2024-09-09 Ying Wang, Ziyuan Shen, Chenlu He, Xing Xing, Zaixiang Tan, Wei Sang
-
Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma Blood Cancer J. (IF 12.9) Pub Date : 2024-09-05 Ricardo D. Parrondo, Betsy R. LaPlant, Jamie Elliott, Andre Fernandez, Caitlin J. Flott, Diedre Arrington, Dustin Chapin, Jade Brown, Saurav Das, Vivek Roy, Asher A. Chanan-Khan, Sikander Ailawadhi
-
Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms Blood Cancer J. (IF 12.9) Pub Date : 2024-09-05 Samantha A. Banks, Paul Decker, Eoin P. Flanagan, Anastasia Zekeridou, Ronald S. Go, Jithma P. Abeykoon, Gaurav Goyal, Jason R. Young, Matthew J. Koster, Robert Vassallo, Jay H. Ryu, Caroline J. Davidge-Pitts, Aishwarya Ravindran, Julio C. Sartori Valinotti, N. Nora Bennani, Mithun V. Shah, Karen L. Rech, Corrie R. Bach, Jeanette E. Eckel-Passow, W. Oliver Tobin
-
Genome profiling with targeted adaptive sampling long-read sequencing for pediatric leukemia Blood Cancer J. (IF 12.9) Pub Date : 2024-08-28 Shota Kato, Aiko Sato-Otsubo, Wataru Nakamura, Masahiro Sugawa, Ai Okada, Kenichi Chiba, Nao Takasugi, Tomoya Irikura, Moe Hidaka, Masahiro Sekiguchi, Kentaro Watanabe, Yuichi Shiraishi, Motohiro Kato
-
Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia Blood Cancer J. (IF 12.9) Pub Date : 2024-08-28 Aimée S. R. Westerveld, Pien Roesthuis, Helena J. H. van der Pal, Dorine Bresters, Marc Bierings, Jacqueline Loonen, Andrica C. H. de Vries, Marloes Louwerens, Maria M. W. Koopman, Marry M. van den Heuvel-Eibrink, Margriet van der Heiden-van der Loo, Peter Hoogerbrugge, Geert O. Janssens, Ronald R. de Krijger, Cecile M. Ronckers, Rob Pieters, Leontien C. M. Kremer, Jop C. Teepen
-
B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation Blood Cancer J. (IF 12.9) Pub Date : 2024-08-28 Lisa Pfeuffer, Viola Siegert, Julia Frede, Leonie Rieger, Riccardo Trozzo, Niklas de Andrade Krätzig, Sandra Ring, Shamim Sarhadi, Nicole Beck, Stefan Niedermeier, Mar Abril-Gil, Mohamed Elbahloul, Marianne Remke, Katja Steiger, Ruth Eichner, Julia Jellusova, Roland Rad, Florian Bassermann, Christof Winter, Jürgen Ruland, Maike Buchner
-
Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance Blood Cancer J. (IF 12.9) Pub Date : 2024-08-27 Kosima Zuern, Thomas Hielscher, Annika Werly, Iris Breitkreutz, Sandra Sauer, Marc S. Raab, Carsten Müller-Tidow, Hartmut Goldschmidt, Elias K. Mai
-
Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel Blood Cancer J. (IF 12.9) Pub Date : 2024-08-27 Rahul Banerjee, Yelak Biru, Craig E. Cole, Beth Faiman, Shonali Midha, Sikander Ailawadhi
-
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma Blood Cancer J. (IF 12.9) Pub Date : 2024-08-27 Baoyan Bai, Jillian F. Wise, Daniel Vodák, Sigve Nakken, Ankush Sharma, Yngvild Nuvin Blaker, Marianne Brodtkorb, Vera Hilden, Gunhild Trøen, Weicheng Ren, Susanne Lorenz, Michael S. Lawrence, Ola Myklebost, Eva Kimby, Qiang Pan-Hammarström, Chloé B. Steen, Leonardo A. Meza-Zepeda, Klaus Beiske, Erlend B. Smeland, Eivind Hovig, Ole Christian Lingjærde, Harald Holte, June Helen Myklebust
-
Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease Blood Cancer J. (IF 12.9) Pub Date : 2024-08-26 Martin Stork, Eva Ondrouskova, Michaela Bohunova, Ivanna Boichuk, Dominik Fric, Zdenek Adam, Marta Krejci, Viera Sandecka, Zdenka Knechtova, Lenka Radova, Zuzana Jelinkova, Tatana Adlerova, Milan Krticka, Vladimir Nekuda, Marek Borsky, Sabina Sevcikova, Marie Jarosova, Ludek Pour
-
Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease Blood Cancer J. (IF 12.9) Pub Date : 2024-08-23 Jialing Lu, Xiebing Bao, Jihao Zhou, Xiaoli Li, Zhewei He, Yujie Ji, Shengli Xue, Suning Chen, Depei Wu, Qi Hu, Peng Ke, Xiao Ma
-
Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification Blood Cancer J. (IF 12.9) Pub Date : 2024-08-23 Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zi-Hao Wang, Zheng Li, Sheng-Li Xue, Hai-Ping Dai
-
Disparities in time to treatment with oral antimyeloma medications Blood Cancer J. (IF 12.9) Pub Date : 2024-08-23 Hamlet Gasoyan, Faiz Anwer, Jeffrey D. Kovach, Nicholas J. Casacchia, Ming Wang, Jason Valent, Michael T. Halpern, Michael B. Rothberg
-
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial Blood Cancer J. (IF 12.9) Pub Date : 2024-08-21 Gianluca Cavallaro, Anna Grassi, Chiara Pavoni, Maria Caterina Micò, Alessandro Busca, Irene Maria Cavattoni, Stella Santarone, Carlo Borghero, Attilio Olivieri, Giuseppe Milone, Patrizia Chiusolo, Pellegrino Musto, Riccardo Saccardi, Francesca Patriarca, Fabrizio Pane, Giorgia Saporiti, Paolo Rivela, Elisabetta Terruzzi, Raffaella Cerretti, Giuseppe Marotta, Angelo Michele Carella, Arnon Nagler, Domenico
-
Survival of patients with classical Hodgkin lymphoma in Finland: a national population-based analysis Blood Cancer J. (IF 12.9) Pub Date : 2024-08-20 Noora Hannuksela, Anu Partanen, Anna Anttalainen, Liisa Ukkola-Vuoti, Iiro Toppila, Johanna Vikkula, Katja Marin, Hanne Kuitunen, Tatu Miettinen, Outi Kuittinen, Aino Rönkä
-
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance Blood Cancer J. (IF 12.9) Pub Date : 2024-08-20 Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus M. Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Roman Hajek, Göran Hallmans, Ulrika Pettersson-Kymmer, Florentin Späth, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
-
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity Blood Cancer J. (IF 12.9) Pub Date : 2024-08-19 Judith Lind, Osman Aksoy, Michaela Prchal-Murphy, Fengjuan Fan, Mariateresa Fulciniti, Dagmar Stoiber, Latifa Bakiri, Erwin F. Wagner, Elisabeth Zwickl-Traxler, Martin Sattler, Karoline Kollmann, Sonia Vallet, Klaus Podar
-
A roadmap towards improving outcomes in multiple myeloma Blood Cancer J. (IF 12.9) Pub Date : 2024-08-12 Mohamad Mohty, Thierry Facon, Florent Malard, Jean-Luc Harousseau
Multiple myeloma (MM) is a chronic hematologic malignancy that remains incurable, because most patients eventually relapse or become refractory to current treatments. MM is a major health problem, with a globally increasing incidence. While, increase in the choice of MM treatment, including new immunotherapies (bispecific monoclonal antibodies and chimeric antigen receptor (CAR)-T cell therapy), may
-
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma Blood Cancer J. (IF 12.9) Pub Date : 2024-08-12 Rajshekhar Chakraborty, Heloise Cheruvalath, Anannya Patwari, Aniko Szabo, Carolina Schinke, Binod Dhakal, Suzanne Lentzsch, Anita D’Souza, Ghulam Rehman Mohyuddin, Kelley Julian, Shonali Midha, Patrick Costello, Martin Kaiser, Melissa Ng Liet Hing, Simon J. Harrison, Edward R. Scheffer Cliff, Meera Mohan
-
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm Blood Cancer J. (IF 12.9) Pub Date : 2024-08-12 Charlotte Pawlyn, Fredrik H. Schjesvold, David A. Cairns, L. J. Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos, Jacob Laubach, Katja Weisel, Heinz Ludwig, S. Vincent Rajkumar, Pieter Sonneveld, Graham Jackson, Gareth Morgan, Paul G. Richardson
-
Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management. Blood Cancer J. (IF 12.9) Pub Date : 2024-08-12 Arushi Khurana,Allison C Rosenthal,Razan Mohty,Mamatha Gaddam,Radhika Bansal,Matthew A Hathcock,Adrienne N Nedved,Urshila Durani,Madiha Iqbal,Yucai Wang,Jonas Paludo,J C Villasboas,David Dingli,Taxiarchis Kourelis,Nelson Leung,Hassan Alkhateeb,Michael W Ruff,Alice Gallo de Moraes,Paschalis Vergidis,Joerg Herrmann,Saad S Kenderian,N Nora Bennani,Patrick B Johnston,Stephen M Ansell,Yi Lin
-
Flow cytometric analysis of erythroid precursors and mutational signatures of lower risk myelodysplastic syndromes identify responders to erythroid stimulating agents Blood Cancer J. (IF 12.9) Pub Date : 2024-08-07 Marco G. Raddi, Sara Bencini, Benedetta Peruzzi, Giorgio Mattiuz, Sven De Pourcq, Michele Tanturli, Nicolas Chapuis, Angela Consagra, Luca Rigodanza, Cristina Amato, Alessandro Sanna, Elena Tofacchi, Enrico Attardi, Sophie Park, Olivier Kosmider, Francesco Annunziato, Michaela Fontenay, Valeria Santini
-
Dynamics of microcyst-like epithelial changes associated with Belantamab mafodotin therapy in a patient with multiple myeloma—a case report Blood Cancer J. (IF 12.9) Pub Date : 2024-08-07 Lukas Schloesser, Karin U. Loeffler, Annkristin Heine, Frank G. Holz, Martina C. Herwig-Carl
-
Serum levels of B-cell activating factor are associated with a reduced risk of chronic lymphocytic leukemia Blood Cancer J. (IF 12.9) Pub Date : 2024-08-07 Eleanor Frost, Jonathan N. Hofmann, Wen-Yi Huang, Ashley A. Frazer-Abel, Kevin D. Deane, Sonja I. Berndt
-
Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligence Blood Cancer J. (IF 12.9) Pub Date : 2024-08-07 J. Martinez-Lopez, N. Lopez-Muñoz, A. Chari, S. Dorado, S. Barrio, S. Arora, A. Kumar, A. Chung, T. Martin, J. Wolf
-
Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial Blood Cancer J. (IF 12.9) Pub Date : 2024-08-07 Lixin Wang, Chuling Fang, Qingzheng Kang, Wenfa Huang, Ziren Chen, Weiqiang Zhao, Lei Wang, Yiran Wang, Kun Tan, Xiao Guo, Yuanyuan Xu, Shuhong Wang, Lijun Wang, Jingqiao Qiao, Zhixiong Tang, Chuan Yu, Yang Xu, Yisheng Li, Li Yu
-
Identification of genetic subtypes in follicular lymphoma Blood Cancer J. (IF 12.9) Pub Date : 2024-08-07 Victoria Shelton, Rajesh Detroja, Ting Liu, Keren Isaev, Anjali Silva, Verena Passerini, Mehran Bakhtiari, Lourdes Calvente, Michael Hong, Michael Y. He, Saloni Modi, Samantha A. Hershenfeld, Maja Ludvigsen, Charlotte Madsen, Stephen Hamilton-Dutoit, Francesco Annibale d’Amore, Marianne Brodtkorb, Nathalie A. Johnson, Tara Baetz, David LeBrun, Josh W. D. Tobin, Maher K. Gandhi, Andrew J. Mungall, Wei
-
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood Cancer J. (IF 12.9) Pub Date : 2024-08-07 Jayastu Senapati,Elias Jabbour,Nicholas J Short,Nitin Jain,Fadi Haddad,Tharakeswara Bathala,Iuliia Kovalenko,Aram Bidikian,Farhad Ravandi,Issa Khouri,Tapan M Kadia,Rebecca Garris,Guillermo Montalban Bravo,Kelly Chien,Elizabeth Shpall,Partow Kebriaei,Hagop M Kantarjian
-
Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms. Blood Cancer J. (IF 12.9) Pub Date : 2024-07-31 Dragan Jevremovic,Min Shi,Pedro Horna,Gregory E Otteson,Michael M Timm,Linda B Baughn,Patricia T Greipp,Wilson I Gonsalves,Prashant Kapoor,Morie A Gertz,Moritz Binder,Francis K Buadi,Jiehao Zhou,Angela Dispenzieri,Taxiarchis Kourelis,Eli Muchtar,S Vincent Rajkumar,Shaji K Kumar,Horatiu Olteanu
-
Non-canonical FLT3 alterations reveal novel germline FLT3 variants leading to somatic gene rescue mutations Blood Cancer J. (IF 12.9) Pub Date : 2024-07-30 Jaymeson Gordon, Carlos Bravo-Perez, Luca Guarnera, Serhan Unlu, Naomi Kawashima, Arooj Ahmed, Christopher Haddad, Yasuo Kubota, Ishani Nautiyal, Fauzia Ullah, Danai Dima, Nakisha D. Williams, Tariq Kewan, Waled Bahaj, Hetty E. Carraway, Chao-Yie Yang, Carmelo Gurnari, Valeria Visconte, Jaroslaw P. Maciejewski
-
IgG replacement in multiple myeloma Blood Cancer J. (IF 12.9) Pub Date : 2024-07-25 Alex Wonnaparhown, Talal Hilal, Jacqueline Squire, Catherine Freeman, Rafael Fonseca
-
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma Blood Cancer J. (IF 12.9) Pub Date : 2024-07-23 Matthew J. Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, Mohammed E. Elhaj, Arwa Bohra, Radhika Bansal, Sikander Ailawadhi, Ricardo Parrondo, Saurabh Chhabra, Amit Khot, Suzanne Hayman, Angela Dispenzieri, Francis Buadi, David Dingli, Rahma Warsame, Prashant Kapoor, Morie A. Gertz, Eli Muchtar, Taxiarchis Kourelis, Wilson Gonsalves, S. Vincent Rajkumar, Yi Lin, Shaji Kumar
-
Prevalence and distribution of M-proteins in the oncologic population affected by solid tumor Blood Cancer J. (IF 12.9) Pub Date : 2024-07-22 Renato de Falco, Giulia Togo, Anita Minopoli, Marco Cuomo, Domenica Rea, Serena Meola, Ernesta Cavalcanti
-
Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia Blood Cancer J. (IF 12.9) Pub Date : 2024-07-22 Yiyi Yao, Yile Zhou, Nanfang Zhuo, Wanzhuo Xie, Haitao Meng, Yinjun Lou, Liping Mao, Hongyan Tong, Jiejing Qian, Min Yang, Wenjuan Yu, De Zhou, Jie Jin, Huafeng Wang
-
Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia Blood Cancer J. (IF 12.9) Pub Date : 2024-07-22 Dagmar Schinnerl, Marion Riebler, Angela Schumich, Sabrina Haslinger, Alice Bramböck, Andrea Inthal, Marek Nykiel, Margarita Maurer-Granofszky, Oskar A. Haas, Ulrike Pötschger, Stefan Köhrer, Karin Nebral, Michael N. Dworzak, Andishe Attarbaschi, Sabine Strehl
-
Racial disparities in multiple myeloma and access to stem cell transplantation. Blood Cancer J. (IF 12.9) Pub Date : 2024-07-22 Joselle Madonna Cook
-
Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features Blood Cancer J. (IF 12.9) Pub Date : 2024-07-19 Mihir D. Wechalekar, Lin-Pierre Zhao, Monika M. Kutyna, Lih En Hong, Joule Li, Kevin Hung, Hamish S. Scott, Anna Brown, Christopher C. Hahn, Karin Kassahn, Dariusz Ladon, David T. Yeung, Daniel Thomas, Mrinal Patnaik, Susanna Proudman, Lionel Ades, Mithun V. Shah, Chung H. Kok, Devendra K. Hiwase
-
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma Blood Cancer J. (IF 12.9) Pub Date : 2024-07-19 Bachisio Ziccheddu, Claudia Giannotta, Mattia D’Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva, Elisa Genuardi, Marios Papadimitriou, Benjamin Diamond, Paolo Corradini, David Coffey, Ola Landgren, Niccolò Bolli, Benedetto Bruno, Mario Boccadoro, Massimo Massaia, Francesco Maura, Alessandra Larocca
-
Long term responders in frontline multiple myeloma-exception vs expectation of the modern era. Blood Cancer J. (IF 12.9) Pub Date : 2024-07-17 Muhamed Baljevic,Douglas W Sborov,Shaji K Kumar
-
Using Mendelian Randomisation to search for modifiable risk factors influencing the development of clonal haematopoiesis Blood Cancer J. (IF 12.9) Pub Date : 2024-07-16 Jessica M. Hislop, Molly Went, Charlie Mills, Amit Sud, Philip J. Law, Richard S. Houlston
-
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia Blood Cancer J. (IF 12.9) Pub Date : 2024-07-15 Qian Wu, Xiaofei Yang, Jingren Zhang, Mengxing Xue, Xueqing Dou, Zheng Ge, Yifei Chen, Weiying Gu, Weimin Dong, Hongying Cao, Naike Jiang, Xuemei Sun, Zefa Liu, Jinning Shi, Hui Chen, Cixian Zhang, Fengling Min, Hongli Sun, Xiaoli Qian, Hongjian Yuan, Yuan Feng, De-Pei Wu, Suning Chen
-
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia Blood Cancer J. (IF 12.9) Pub Date : 2024-07-12 Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H. Wiseman
-
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19 Blood Cancer J. (IF 12.9) Pub Date : 2024-07-10 Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, Camila Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesus F. San-Miguel, Paula Rodriguez-Otero, Bruno Paiva
-
Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation Blood Cancer J. (IF 12.9) Pub Date : 2024-07-08 Jiayu Huang, Bingyang Shi, Suhui Yu, Mengxing Xue, Ling Wang, Jieling Jiang, Jiong Hu, Jun Zhu, Suning Chen, Lijing Shen, Weijie Cao, Yang Cao, Xiaoxia Hu
-
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission Blood Cancer J. (IF 12.9) Pub Date : 2024-07-08 Mazyar Shadman, Kwang W. Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M. Hossain, Peter Riedell, Ajay K. Gopal, Natalie Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid Merryman, Aleksandr Lazaryan, Ron Ram, Mark Hertzberg, Bipin Savani, Farrukh Awan, Farhad Khimani, Sairah Ahmed, Vaishalee P. Kenkre, Matthew Ulrickson, Nirav
-
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN Blood Cancer J. (IF 12.9) Pub Date : 2024-07-08 Ajai Chari, Jonathan L. Kaufman, Jacob Laubach, Douglas W. Sborov, Brandi Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano J. Costa, Larry D. Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Kenneth H. Shain, Andrew J. Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S. Lin, Peter M. Voorhees
-
Improving outcomes with anti-BCMA bispecific antibodies with attention to infection. Blood Cancer J. (IF 12.9) Pub Date : 2024-07-08 Andrew J Yee
-
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years Blood Cancer J. (IF 12.9) Pub Date : 2024-07-05 Philipp Berning, Mathilde Fekom, Maud Ngoya, Anthony H. Goldstone, Peter Dreger, Silvia Montoto, Hervé Finel, Evgenii Shumilov, Patrice Chevallier, Didier Blaise, Tim Strüssmann, Ben Carpenter, Edouard Forcade, Cristina Castilla-Llorente, Marek Trneny, Hervé Ghesquieres, Saveria Capria, Catherine Thieblemont, Igor Wolfgang Blau, Ellen Meijer, Annoek E. C. Broers, Anne Huynh, Denis Caillot, Wolf Rösler
-
Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing data Blood Cancer J. (IF 12.9) Pub Date : 2024-07-04 Richard Norris, John Jones, Erika Mancini, Timothy Chevassut, Fabio A. Simoes, Chris Pepper, Andrea Pepper, Simon Mitchell
-
Are thrombosis, progression, and survival in ET predictable? Blood Cancer J. (IF 12.9) Pub Date : 2024-06-25 Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Ahamed Lebbe, Imane Bouhali, Mohammed Khalid, Richard T. Silver, Joseph M. Scandura
-
Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia Blood Cancer J. (IF 12.9) Pub Date : 2024-06-24 Maria L. Salustiano-Bandeira, Amanda Moreira-Aguiar, Diego A. Pereira-Martins, Juan L. Coelho-Silva, Isabel Weinhäuser, Pedro L. França-Neto, Aleide S. Lima, Ana S. Lima, Anemari R. Baccarin, Fernanda B. Silva, Manuela A. de Melo, Fernanda S. Niemann, Luciana Nardinelli, César A. Ortiz Rojas, Bruno K. Duarte, Aderson S. Araujo, Elisa A. Azevedo, Clarice N. Morais, Lorena L. Figueiredo-Pontes, Jan J
-
Clinical features and outcomes in primary nervous system histiocytic neoplasms Blood Cancer J. (IF 12.9) Pub Date : 2024-06-20 Nabeela Nathoo, Joon H. Uhm, Alyx B. Porter, Julie Hammack, Kurt A. Jaeckle, Maciej M. Mrugala, Brian A. Crum, Eoin P. Flanagan, Sean J. Pittock, Gaurav Goyal, Jason R. Young, Matthew J. Koster, Robert Vassallo, Jay H. Ryu, Caroline J. Davidge-Pitts, Corrie Bach, Aishwarya Ravindran, Julio C. Sartori Valinotti, N. Nora Bennani, Jithma P. Abeykoon, Mithun V. Shah, C. Christopher Hook, Karen L. Rech
-
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL Blood Cancer J. (IF 12.9) Pub Date : 2024-06-20 Kerstin Wenzl, Matthew E. Stokes, Joseph P. Novak, Allison M. Bock, Sana Khan, Melissa A. Hopper, Jordan E. Krull, Abigail R. Dropik, Janek S. Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C. Chris Huang, Matthew J. Maurer, Lisa Rimsza, Brian K. Link, Susan L. Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Andrew
-
Anti-CD5 CAR-T cells with a tEGFR safety switch exhibit potent toxicity control Blood Cancer J. (IF 12.9) Pub Date : 2024-06-18 Haolong Lin, Jiali Cheng, Li Zhu, Yuhao Zeng, Zhenyu Dai, Yicheng Zhang, Xiaojian Zhu, Wei Mu
-
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms Blood Cancer J. (IF 12.9) Pub Date : 2024-06-18 Amandeep Kaur, Alexandra E. Rojek, Emily Symes, Mariam T. Nawas, Anand A. Patel, Jay L. Patel, Payal Sojitra, Barina Aqil, Madina Sukhanova, Megan E. McNerney, Leo P. Wu, Aibek Akmatbekov, Jeremy Segal, Melissa Y. Tjota, Sandeep Gurbuxani, Jason X. Cheng, Su-Yeon Yeon, Harini V. Ravisankar, Carrie Fitzpatrick, Angela Lager, Michael W. Drazer, Caner Saygin, Pankhuri Wanjari, Panagiotis Katsonis, Olivier
-
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study Blood Cancer J. (IF 12.9) Pub Date : 2024-06-13 Pierre Hirsch, Jérôme Lambert, Maxime Bucci, Caroline Deswarte, Augustin Boudry, Juliette Lambert, Laurene Fenwarth, Jean-Baptiste Micol, Christine Terré, Karine Celli-Lebras, Xavier Thomas, Hervé Dombret, Nicolas Duployez, Claude Preudhomme, Raphael Itzykson, Francois Delhommeau
-
Premature thymic functional senescence is a hallmark of childhood acute lymphoblastic leukemia survivorship Blood Cancer J. (IF 12.9) Pub Date : 2024-06-13 Tibila Kientega, Sophie Marcoux, Jessica Bourbonnais, Jade Montpetit, Maxime Caru, Guillaume B. Cardin, Nathalie Arbour, Valérie Marcil, Daniel Curnier, Caroline Laverdière, Daniel Sinnett, Francis Rodier
-
Performance of newer myeloma staging systems in a contemporary, large patient cohort Blood Cancer J. (IF 12.9) Pub Date : 2024-06-11 Ghulam Rehman Mohyuddin, Samuel M. Rubinstein, Shaji Kumar, S. Vincent Rajkumar, Rafael Fonseca, Nadine H. Abdallah, Gregory S. Calip, Xiaoyan Wang, Christina M. Parrinello, Douglas Sborov
-
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells Blood Cancer J. (IF 12.9) Pub Date : 2024-06-07 Mattia D’Agostino, Delia Rota-Scalabrini, Angelo Belotti, Luca Bertamini, Maddalena Arigoni, Giovanni De Sabbata, Giuseppe Pietrantuono, Anna Pascarella, Patrizia Tosi, Francesco Pisani, Norbert Pescosta, Marina Ruggeri, Jennifer Rogers, Martina Olivero, Mariagrazia Garzia, Piero Galieni, Ombretta Annibali, Federico Monaco, Anna Marina Liberati, Salvatore Palmieri, Paola Stefanoni, Elena Zamagni, Benedetto
-
Extended DaraKRd: Are we enhancing outcomes by prolonging treatment? Blood Cancer J. (IF 12.9) Pub Date : 2024-06-04 Timothy M Schmidt
更新日期：2024-09-10
Copyright © 2014-2024 北京衮雪科技有限公司 All Rights Reserved
京ICP备11026495号-2
京公网安备 11010802027423号
京公网安备 11010802027423号